713 related articles for article (PubMed ID: 17462864)
1. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
[TBL] [Abstract][Full Text] [Related]
2. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use and psychotic disorders: an update.
Hall W; Degenhardt L; Teesson M
Drug Alcohol Rev; 2004 Dec; 23(4):433-43. PubMed ID: 15763748
[TBL] [Abstract][Full Text] [Related]
4. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
[TBL] [Abstract][Full Text] [Related]
5. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
Dubertret C; Bidard I; Adès J; Gorwood P
Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837
[TBL] [Abstract][Full Text] [Related]
6. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults.
McGrath J; Welham J; Scott J; Varghese D; Degenhardt L; Hayatbakhsh MR; Alati R; Williams GM; Bor W; Najman JM
Arch Gen Psychiatry; 2010 May; 67(5):440-7. PubMed ID: 20194820
[TBL] [Abstract][Full Text] [Related]
7. [Cannabis and psychosis--a review].
Schaub M; Rössler W; Stohler R
Praxis (Bern 1994); 2004 Jun; 93(23):997-1002. PubMed ID: 15233568
[TBL] [Abstract][Full Text] [Related]
8. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases.
Niemi-Pynttäri JA; Sund R; Putkonen H; Vorma H; Wahlbeck K; Pirkola SP
J Clin Psychiatry; 2013 Jan; 74(1):e94-9. PubMed ID: 23419236
[TBL] [Abstract][Full Text] [Related]
9. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
[TBL] [Abstract][Full Text] [Related]
10. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
Flanders SE
Aust N Z J Psychiatry; 2007 Nov; 41(11):934-6. PubMed ID: 17924247
[TBL] [Abstract][Full Text] [Related]
11. [Does cannabis use lead to schizophrenia?].
Heekeren K
Praxis (Bern 1994); 2011 Nov; 100(22):1361-7. PubMed ID: 22048912
[TBL] [Abstract][Full Text] [Related]
12. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
13. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.
Chen CK; Lin SK; Sham PC; Ball D; Loh EW; Hsiao CC; Chiang YL; Ree SC; Lee CH; Murray RM
Psychol Med; 2003 Nov; 33(8):1407-14. PubMed ID: 14672249
[TBL] [Abstract][Full Text] [Related]
14. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
Jockers-Scherübl MC
Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of symptom patterns of cannabis-induced psychosis.
Imade AG; Ebie JC
Acta Psychiatr Scand; 1991 Feb; 83(2):134-6. PubMed ID: 2017910
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
[TBL] [Abstract][Full Text] [Related]
17. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L
Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative symptoms in affected sib pairs with schizophrenia: implications for genetic studies in an African Xhosa sample.
Niehaus DJ; Koen L; Laurent C; Muller J; Deleuze JF; Mallet J; Seller C; Jordaan E; Emsley R
Schizophr Res; 2005 Nov; 79(2-3):239-49. PubMed ID: 15993564
[TBL] [Abstract][Full Text] [Related]
19. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
Hambrecht M; Häfner H
Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
[TBL] [Abstract][Full Text] [Related]
20. High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.
Hall W; Degenhardt L
BMJ; 2015 Mar; 350():h1205. PubMed ID: 25739398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
